The company begins phase 1 trials of oral GAL-101, targeting amyloid beta aggregation. Promising safety and efficacy in ophthalmic models suggest potential for treating dry AMD, glaucoma, and neurodegenerative eye diseases.
Quick visual recovery is important for this young population
Study compares preoperative risk factors, co-pathology in patients
Study compares preoperative risk factors, co-pathology in patients
Study compares preoperative risk factors, co-pathology in patients
Study compares preoperative risk factors, co-pathology in patients
Study compares preoperative risk factors, co-pathology in patients
Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 4 of the Viewpoints Podcast.
Patients report improved intermediate vision, quality distance sight after surgery
Why low-lying lids can affect much more than patients' visual field, with implications for visual quality and their self-esteem.
COVID-19 pandemic is accelerating cultural paradigm shift for medical professionals
Study results demonstrate effectiveness in treating dry age-related macular degeneration
A tailored treatment plan can help surgeons offer personalized care for patients.
New acrylic implant provides option for patients with endothelial dysfunction.